
Faes Farma S.A.
Develops and markets pharmaceuticals, like antihistamines, and animal nutrition products globally.
FAE | MC
Overview
Corporate Details
- ISIN(s):
- ES0134950F36
- LEI:
- 959800FXZQY7U3P1G969
- Country:
- Spain
- Address:
- AVENIDA AUTONOMIA, 10-, 48940 Leioa
- Website:
- https://faesfarma.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Faes Farma S.A. is an international pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceuticals and animal nutrition products. With a history of over 90 years, the company operates two main business lines. The pharmaceutical division focuses on therapeutic areas such as allergies, gastroenterology, and immunology, with key proprietary molecules including the antihistamine Bilastine and Vitamin D treatment Calcifediol. The animal nutrition division provides specialized feeds and nutritional solutions, particularly for swine, through brands like Ingaso Farm and Tecnovit. The company emphasizes innovation through significant R&D investment and has a global presence with direct commercial operations across Europe, Latin America, Africa, and the Middle East.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Faes Farma S.A. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-07-16 00:00 |
Post-Annual General Meeting Information
Acuerdo Junta Extraordinaria de Accionistas
|
Spanish | 115.9 KB | |
2025-06-25 00:00 |
Post-Annual General Meeting Information
Aspectos relevantes de la Junta de Accionistas 2025
|
Spanish | 159.0 KB | |
2025-06-25 00:00 |
Investor Presentation
Presentación Junta de Accionistas 2025
|
Spanish | 4.2 MB | |
2025-06-11 00:00 |
Pre-Annual General Meeting Information
Junta General Extraordinaria de Accionistas
|
Spanish | 167.3 KB | |
2025-05-19 15:51 |
Pre-Annual General Meeting Information
Convocatoria de la Junta General de Accionistas de 2025
|
Spanish | 180.2 KB | |
2025-05-19 00:00 |
Pre-Annual General Meeting Information
Convocatoria de la Junta General de Accionistas de 2025
|
Spanish | 180.2 KB | |
2025-05-06 08:25 |
Investor Presentation
Informe de negocio del primer trimestre de 2025
|
Spanish | 1.7 MB | |
2025-04-29 16:08 |
Report Publication Announcement
Faes Farma anuncia la celebración de un webcast para presentar los resultados d…
|
Spanish | 65.2 KB | |
2025-04-22 11:39 |
Investor Presentation
Presentación Capital Markets Day 2025
|
Spanish | 4.7 MB | |
2025-04-22 09:56 |
Investor Presentation
La Sociedad comunica que hoy celebrará su Capital Markets Day para presentar el…
|
Spanish | 55.7 KB | |
2025-03-25 18:09 |
M&A Activity
Faes Farma S.A. ha suscrito un contrato para la adquisición de Laboratorios Edo…
|
Spanish | 67.7 KB | |
2025-02-28 07:55 |
Investor Presentation
Informe de negocio y resultados 2024
|
Spanish | 1.2 MB | |
2025-02-28 07:52 |
Major Shareholding Notification
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
|
Spanish | 426.0 KB | |
2025-02-28 07:51 |
Remuneration Information
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
|
Spanish | 213.3 KB | |
2025-02-28 00:00 |
Annual / Quarterly Financial Statement
|
Spanish | 12.1 MB |
Automate Your Workflow. Get a real-time feed of all Faes Farma S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Faes Farma S.A. via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |